Lisdexamfetamine
Top View
- Lisdexamfetamine for the Management of Acute Methamphetamine Withdrawal: Protocol for an Open-Label Safety and Feasibility Study
- Efficacy of Lisdexamfetamine in Adults with Moderate to Severe Binge
- Download 2019 Aggregate Production Quota NPRM
- Dopaminergic Stimulants and Risk of Parkinson's Disease
- Vyvanse (Lisdexamfetamine)
- Treatment of Stimulant Use Disorders: Current Practices and Promising Perspectives
- Algorithm for the Psychopharmacological Management of Attention Deficit Hyperactivity Disorder (ADHD) Revised May 2009 Steven R
- Progress in Developing Pharmacologic Agents to Treat Bulimia Nervosa
- Clinical Considerations Regarding the Use of Obesity Pharmacotherapy in Adolescents with Obesity Gitanjali Srivastava 1, Claudia K
- (12) United States Patent (10) Patent No.: US 8,779,191 B2 Bauer Et Al
- Efficacy of Lisdexamfetamine Dimesylate in Adults with Attention
- Prescribing Guidelines for Behavioral Health
- A Study Protocol for a Randomised, Double-Blind, Placebo Controlled Trial of Lisdexamfetamine for the Treatment of Methamphetamine Dependence
- Advanced ADHD Psychopharm
- (12) United States Patent (10) Patent No.: US 8,318,813 B2 Sanfilippo (45) Date of Patent: Nov
- Pharmaabkommen A1 E
- Repurposing Low Dose Lisdexamfetamine As Agonist Therapy for Stimulant Use Disorder: a Case Series
- Stimulant Comparisons